|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01548 GENSCRIPT BIO
Nominal 
10.820 0.000 (0.000%) Profitability Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| ROAA (%) | -3.218% | -9.491% | -19.488% | -17.541% | -10.730% |
| ROAE (%) | -7.951% | -22.061% | -36.834% | -31.910% | -22.499% |
| Return on Capital Employed (%) | -3.301% | -11.340% | -19.703% | -18.307% | -14.575% |
Margin Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Gross Profit Margin (%) | 48.784% | 48.599% | 57.645% | 65.472% | 65.955% |
| EBITDA Margin (%) | -29.545% | -56.600% | -95.898% | -63.266% | -36.696% |
| Pre-tax Profit Margin (%) | -41.807% | -68.993% | -105.564% | -72.126% | -41.591% |
| Net Profit Margin (%) | -11.373% | -36.256% | -73.192% | -52.436% | -35.453% |
Liquidity Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Current Ratio (X) | 4.756 X | 3.233 X | 3.966 X | 3.029 X | 2.468 X |
| Quick Ratio (X) | 4.648 X | 3.123 X | 3.858 X | 2.932 X | 2.394 X |
Leverage Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Total Liabilities / Total Assets(%) | 39.647% | 46.486% | 37.879% | 43.652% | 58.141% |
| Total Debt / Total Assets (%) | 12.310% | 13.737% | 7.004% | 3.800% | 2.713% |
| Net Debt / Total Assets (%) | -30.390% | -26.477% | -45.863% | -39.661% | -25.665% |
| Total Debt / Shareholders' Funds (%) | 29.976% | 34.615% | 14.957% | 6.100% | 6.304% |
| Long Term Debt / Shareholders' Funds (%) | 25.240% | 30.183% | 14.189% | 0.862% | 1.399% |
| Net Debt / Shareholders' Funds (%) | -74.001% | -66.717% | -97.947% | -63.663% | -59.629% |
| Net Cash / (Debt) ($) | 1.029B | 674.200M | 1.025B | 574.055M | 228.264M |
| Net Cash / (Debt) per share ($) | 0.485 | 0.319 | 0.488 | 0.294 | 0.122 |
| Total Debt / Capital Employed (%) | 14.416% | 17.486% | 8.593% | 4.913% | 3.630% |
| Interest Coverage Ratio (X) | N/A | N/A | N/A | N/A | N/A |
Efficiency Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Inventory Turnover (Day) | 48.081 Day | 59.181 Day | 66.909 Day | 65.224 Day | 56.703 Day |
| Receivables Turnover (Day) | 70.238 Day | 71.961 Day | 105.824 Day | 100.305 Day | 94.076 Day |
| Payables Turnover (Day) | 20.807 Day | 25.064 Day | 19.941 Day | 19.146 Day | 19.237 Day |
| Remarks: | Real time quote last updated: 15/11/2024 08:52 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders ($) | USD -175,115,000 |
| %Change | 87.127% |
| EPS / (LPS) | USD -0.083 |
| NBV Per Share ($) | USD 0.571 |